Published in Cancer Res on April 15, 1995
Activating mutations in ALK provide a therapeutic target in neuroblastoma. Nature (2008) 6.80
Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta. Proc Natl Acad Sci U S A (2000) 2.15
Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy. Expert Rev Anticancer Ther (2009) 1.73
Nuclear targeting by the growth factor midkine. Mol Cell Biol (2002) 1.44
Neointima formation in a restenosis model is suppressed in midkine-deficient mice. J Clin Invest (2000) 1.37
Serum midkine levels are increased in patients with various types of carcinomas. Br J Cancer (2000) 1.34
Midkine induces the transformation of NIH3T3 cells. Br J Cancer (1997) 1.33
miR-1289 and "Zipcode"-like Sequence Enrich mRNAs in Microvesicles. Mol Ther Nucleic Acids (2012) 1.18
Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases. Proc Jpn Acad Ser B Phys Biol Sci (2010) 1.16
Clinical significance of midkine expression in pancreatic head carcinoma. Br J Cancer (2007) 1.12
Pleiotrophin regulates serine phosphorylation and the cellular distribution of beta-adducin through activation of protein kinase C. Proc Natl Acad Sci U S A (2005) 1.10
Expression of midkine in the early stage of carcinogenesis in human colorectal cancer. Br J Cancer (1999) 1.09
Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes. BMC Cancer (2007) 1.06
Functional divergence of two zebrafish midkine growth factors following fish-specific gene duplication. Genome Res (2003) 1.06
Solution structure of midkine, a new heparin-binding growth factor. EMBO J (1997) 1.05
Midkine: a promising molecule for drug development to treat diseases of the central nervous system. Curr Pharm Des (2011) 1.04
Growth factor midkine is involved in the pathogenesis of diabetic nephropathy. Am J Pathol (2006) 1.00
Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK. Neoplasia (2009) 0.97
In vitro and in vivo suppression of hepatocellular carcinoma growth by midkine-antisense oligonucleotide-loaded nanoparticles. World J Gastroenterol (2009) 0.93
Truncated midkine as a marker of diagnosis and detection of nodal metastases in gastrointestinal carcinomas. Br J Cancer (1998) 0.92
Correlation of elevated level of blood midkine with poor prognostic factors of human neuroblastomas. Br J Cancer (2003) 0.92
Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases. Br J Pharmacol (2014) 0.87
Premature ligand-receptor interaction during biosynthesis limits the production of growth factor midkine and its receptor LDL receptor-related protein 1. J Biol Chem (2011) 0.84
Involvement of midkine in neuroblastoma tumourigenesis. Br J Pharmacol (2014) 0.84
Enhanced therapeutic effects of combined chemotherapeutic drugs and midkine antisense oligonucleotides for hepatocellular carcinoma. World J Gastroenterol (2007) 0.83
Midkine as a prognostic marker for gastrointestinal stromal tumors. J Cancer Res Clin Oncol (2007) 0.82
Midkine as a prognostic biomarker in oral squamous cell carcinoma. Br J Cancer (2008) 0.82
Midkine: a novel prognostic biomarker for cancer. Cancers (Basel) (2010) 0.81
Promotion of self-renewal of embryonic stem cells by midkine. Acta Pharmacol Sin (2010) 0.81
Midkine translocated to nucleoli and involved in carcinogenesis. World J Gastroenterol (2009) 0.81
Antisense oligonucleotide targeting midkine suppresses in vivo angiogenesis. World J Gastroenterol (2007) 0.80
Ethanol activates midkine and anaplastic lymphoma kinase signaling in neuroblastoma cells and in the brain. J Neurochem (2015) 0.79
Expression of midkine and its clinical significance in esophageal squamous cell carcinoma. World J Gastroenterol (2006) 0.78
Protein-bound carbohydrates on cell-surface as targets of recognition: an odyssey in understanding them. Glycoconj J (2001) 0.78
Midkine is highly expressed in neuroblastoma tissues. Pediatr Surg Int (2008) 0.77
Midkine Mediates Intercellular Crosstalk between Drug-Resistant and Drug-Sensitive Neuroblastoma Cells In Vitro and In Vivo. ISRN Oncol (2013) 0.77
Clinical significance of serum biomarkers in pediatric solid mediastinal and abdominal tumors. Int J Mol Sci (2012) 0.77
PKCδ/midkine pathway drives hypoxia-induced proliferation and differentiation of human lung epithelial cells. Am J Physiol Cell Physiol (2014) 0.77
Expression and purification of bioactive high-purity human midkine in Escherichia coli. J Zhejiang Univ Sci B (2009) 0.75
Midkine is a serum and urinary biomarker for the detection and prognosis of non-small cell lung cancer. Oncotarget (2016) 0.75
Lentivirus-mediated RNAi knockdown of insulin-like growth factor-1 receptor inhibits the growth and invasion of hepatocellular carcinoma via down-regulating midkine expression. Oncotarget (2016) 0.75
Midkine: A Novel Biomarker to Predict Malignancy in Patients with Nodular Thyroid Disease. Int J Endocrinol (2016) 0.75
Stromal gene signatures in large-B-cell lymphomas. N Engl J Med (2008) 11.34
Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science (1984) 9.64
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med (1999) 9.02
Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus. Nature (1983) 8.60
Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med (1985) 7.79
Random-clone strategy for genomic restriction mapping in yeast. Proc Natl Acad Sci U S A (1986) 6.44
Amino acid sequence of human platelet factor 4. Proc Natl Acad Sci U S A (1977) 4.04
Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science (1987) 4.03
Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J Clin Invest (1982) 3.77
Light control of Arabidopsis development entails coordinated regulation of genome expression and cellular pathways. Plant Cell (2001) 3.60
Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Genome Biol (2001) 3.55
Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst (1989) 3.48
Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res (2001) 3.45
Identification of the DNA binding site for NGFI-B by genetic selection in yeast. Science (1991) 3.41
Luteinizing hormone deficiency and female infertility in mice lacking the transcription factor NGFI-A (Egr-1). Science (1996) 3.39
Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival. J Pediatr Hematol Oncol (1999) 3.35
Human platelet-derived growth factor. Purification and resolution into two active protein fractions. J Biol Chem (1981) 3.21
Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol (1991) 3.16
Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci U S A (1981) 3.03
DNA-binding specificity of NGFI-A and related zinc finger transcription factors. Mol Cell Biol (1995) 2.78
Nonconvulsive seizures are common in critically ill children. Neurology (2011) 2.77
Degradation of nuclear oncoproteins by the ubiquitin system in vitro. Proc Natl Acad Sci U S A (1991) 2.77
The c-sis gene encodes a precursor of the B chain of platelet-derived growth factor. EMBO J (1984) 2.77
Preferential amplification of the paternal allele of the N-myc gene in human neuroblastomas. Nat Genet (1993) 2.72
Synaptic transmission deficits in Caenorhabditis elegans synaptobrevin mutants. J Neurosci (1998) 2.57
Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J Cell Biol (1989) 2.54
Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med (1993) 2.52
NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli. Mol Cell Biol (1996) 2.51
Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010. Euro Surveill (2010) 2.49
Rate of functional decline in Huntington's disease. Huntington Study Group. Neurology (2000) 2.49
A global survey of haplotype frequencies and linkage disequilibrium at the DRD2 locus. Hum Genet (1998) 2.44
Comparisons of two methods for haplotype reconstruction and haplotype frequency estimation from population data. Am J Hum Genet (2001) 2.44
Haplotypes and linkage disequilibrium at the phenylalanine hydroxylase locus, PAH, in a global representation of populations. Am J Hum Genet (2000) 2.43
Expression of a platelet-derived growth factor-like protein in simian sarcoma virus transformed cells. Science (1983) 2.41
Transforming protein of simian sarcoma virus stimulates autocrine growth of SSV-transformed cells through PDGF cell-surface receptors. Cell (1984) 2.41
Virological analysis of fatal influenza cases in the United Kingdom during the early wave of influenza in winter 2010/11. Euro Surveill (2011) 2.40
Platelet-derived growth factor stimulates tyrosine-specific protein kinase activity in Swiss mouse 3T3 cell membranes. Proc Natl Acad Sci U S A (1982) 2.39
Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype. Alcohol Clin Exp Res (2000) 2.39
Household exposure to passive cigarette smoking and serum micronutrient concentrations. Am J Clin Nutr (2000) 2.38
A comparison of awake versus paralyzed tracheal intubation for infants with pyloric stenosis. Anesth Analg (1998) 2.38
Evolution of an enzyme activity: crystallographic structure at 2-A resolution of cephalosporinase from the ampC gene of Enterobacter cloacae P99 and comparison with a class A penicillinase. Proc Natl Acad Sci U S A (1993) 2.34
GFR alpha1-deficient mice have deficits in the enteric nervous system and kidneys. Neuron (1998) 2.29
Chemotactic activity of platelet alpha granule proteins for fibroblasts. J Cell Biol (1983) 2.28
Survival and complications in thalassemia. Ann N Y Acad Sci (2005) 2.25
Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc Natl Acad Sci U S A (1989) 2.25
Structural studies of two ovalbumin glycopeptides in relation to the endo-beta-N-acetylglucosaminidase specificity. J Biol Chem (1975) 2.23
Gene targeting reveals a critical role for neurturin in the development and maintenance of enteric, sensory, and parasympathetic neurons. Neuron (1999) 2.22
Some kinetic properties of Bacillus subtilis glutamine synthetase. J Biol Chem (1970) 2.22
Cytogenetic features of human neuroblastomas and cell lines. Cancer Res (1981) 2.21
The cell biology of osteoclast function. J Cell Sci (2000) 2.21
Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. Nat Genet (1998) 2.19
Development of a real-time PCR method for Firmicutes and Bacteroidetes in faeces and its application to quantify intestinal population of obese and lean pigs. Lett Appl Microbiol (2008) 2.19
Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta. Proc Natl Acad Sci U S A (2000) 2.15
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee. Br J Cancer (2009) 2.13
Prognostic signs in the surgical management of plexiform neurofibroma: the Children's Hospital of Philadelphia experience, 1974-1994. J Pediatr (1997) 2.13
Clinical markers of early disease in persons near onset of Huntington's disease. Neurology (2001) 2.11
Bacillus subtilis glutamine synthetase. Purification and physical characterization. J Biol Chem (1970) 2.10
Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors. Structure (1999) 2.09
EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron (2001) 2.08
Participation of non-zinc finger residues in DNA binding by two nuclear orphan receptors. Science (1992) 2.08
Qualitative semi-parametric test for genetic associations in case-control designs under structured populations. Ann Hum Genet (2003) 2.07
Chromosomal aberrations in human neuroblastomas. Cancer (1977) 2.01
Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science (1990) 2.00
A novel programed frameshift expresses the POL3 gene of retrotransposon Ty3 of yeast: frameshifting without tRNA slippage. Cell (1993) 2.00
Endo-beta-N-acetylglucosaminidase acting on carbohydrate moieties of glycoproteins. Purification and properties of the enzyme from Diplococcus pneumoniae. J Biol Chem (1974) 1.99
The orphan receptors NGFI-B and steroidogenic factor 1 establish monomer binding as a third paradigm of nuclear receptor-DNA interaction. Mol Cell Biol (1993) 1.98
Travel time to hospital and treatment for breast, colon, rectum, lung, ovary and prostate cancer. Eur J Cancer (2008) 1.97
cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem Biophys Res Commun (1988) 1.95
Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids. Proc Natl Acad Sci U S A (1995) 1.95
Evaluation of precipitation and direct methods for HDL-cholesterol assay by HPLC. Clin Chem (1997) 1.95
Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies. J Clin Oncol (1996) 1.94
Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282. Ann Oncol (2001) 1.94
A null mutation in basigin, an immunoglobulin superfamily member, indicates its important roles in peri-implantation development and spermatogenesis. Dev Biol (1998) 1.94
Unimpaired thymic and peripheral T cell death in mice lacking the nuclear receptor NGFI-B (Nur77). Science (1995) 1.93
Expression and function of TRK-B and BDNF in human neuroblastomas. Mol Cell Biol (1994) 1.92
Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription. Proc Natl Acad Sci U S A (1995) 1.89
Adolescents' perceptions of factors affecting their decisions to seek health care. JAMA (1995) 1.89
Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRalpha3-RET receptor complex. Neuron (1998) 1.89
The early response gene NGFI-C encodes a zinc finger transcriptional activator and is a member of the GCGGGGGCG (GSG) element-binding protein family. Mol Cell Biol (1991) 1.88
The GDNF family ligands and receptors - implications for neural development. Curr Opin Neurobiol (2000) 1.88
Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study. J Clin Oncol (1998) 1.88
Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy. Neurology (2011) 1.86
RET signaling is essential for migration, axonal growth and axon guidance of developing sympathetic neurons. Development (2001) 1.86
High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Clin Cancer Res (2000) 1.85
The human decatenation checkpoint. Proc Natl Acad Sci U S A (2001) 1.84
p53-based blood test for p53PIN3 and risk for sporadic ovarian cancer. Lancet (1995) 1.84
Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature (1996) 1.83
Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase. Implications for the Pim-1-mediated activation of the c-Myc signaling pathway. J Biol Chem (1999) 1.83
Multiple classes of yeast mutants are defective in vacuole partitioning yet target vacuole proteins correctly. Mol Biol Cell (1996) 1.83
A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci U S A (1995) 1.82
Dynamics of neural crest-derived cell migration in the embryonic mouse gut. Dev Biol (2004) 1.81
EGR1 target genes in prostate carcinoma cells identified by microarray analysis. J Biol Chem (2000) 1.80
Platelet-derived growth factor. Specific binding to target cells. J Biol Chem (1982) 1.80
Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene (1999) 1.79
Transformation by v-sis occurs by an internal autoactivation mechanism. Science (1989) 1.79
Growth and differentiation proceeds normally in cells deficient in the immediate early gene NGFI-A. J Biol Chem (1995) 1.77